Back to News
Market Impact: 0.2
Biograph Completes First U.S. Study with Caristo Diagnostics’ AI-Powered Coronary Inflammation Detection, Finding Risk in Over 42% of Asymptomatic Patients
Source: Business Wire
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
A Biograph study found AI imaging detected coronary inflammation in 43% of asymptomatic adults, while standard blood tests did not identify it. The brief report provides no sample size, clinical outcomes, or commercial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- US tech stocks tumble as investors fret over AI spending
- Asian shares wobble as tech rout boosts bonds, dents rate hike bets
- Asia stocks fall as AI rout batters S.Korea; Japan spooked by strong CPI
- AI debt and French bonds face a stress test — why it may not be over
- Nasdaq 100 Drops as Oil Rise Fuels Risk-Off Mood
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Live Event Center, In-App Documents, and Faster Transcripts
- How to Automate Equity Research Workflows: A Control-First Guide